✦ LIBER ✦

Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study

✍ Scribed by Kaku, Kohei; Watada, Hirotaka; Iwamoto, Yasuhiko; Utsunomiya, Kazunori; Terauchi, Yasuo; Tobe, Kazuyuki; Tanizawa, Yukio; Araki, Eiichi; Ueda, Masamichi; Suganami, Hideki; Watanabe, Daisuke

Book ID: 125400381
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 316 KB
Volume: 13
Category: Article
ISSN: 1475-2840
DOI: 10.1186/1475-2840-13-65

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of canagliflozin in

Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, 12-week study

✍ Inagaki, N.; Kondo, K.; Yoshinari, T.; Maruyama, N.; Susuta, Y.; Kuki, H. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 643 KB

Efficacy and safety of canagliflozin mon

Efficacy and safety of canagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study

✍ Inagaki, Nobuya; Kondo, Kazuoki; Yoshinari, Toru; Takahashi, Nahoko; Susuta, Yut 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 708 KB

Linagliptin monotherapy provides superio

Linagliptin monotherapy provides superior glycaemic control versus placebo or voglibose with comparable safety in Japanese patients with type 2 diabetes: a randomized, placebo and active comparator-controlled, double-blind study

✍ R. Kawamori; N. Inagaki; E. Araki; H. Watada; N. Hayashi; Y. Horie; A. Sarashina 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 587 KB

Efficacy and tolerability of exenatide m

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug—naive patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel-group study

✍ Thomas J. Moretto; Denái R. Milton; Terry D. Ridge; Leigh A. MacConell; Ted Oker 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 908 KB

Efficacy and safety of initial combinati

Efficacy and safety of initial combination therapy with linagliptin and pioglitazone in patients with inadequately controlled type 2 diabetes: a randomized, double-blind, placebo-controlled study

✍ R. Gomis; R.-M. Espadero; R. Jones; H. J. Woerle; K. A. Dugi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 849 KB

Efficacy and safety of the dipeptidyl pe

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study*

✍ Pratley, Richard E.; Reusch, Jane E.-B.; Fleck, Penny R.; Wilson, Craig A.; Mekk 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 282 KB